21 USC Part A - Drugs and Devices
- § 351. Adulterated drugs and devices
- § 352. Misbranded drugs and devices
- § 353. Exemptions and consideration for certain drugs, devices, and biological products
- § 353a. Pharmacy compounding
- § 353b. Prereview of television advertisements
- § 354. Veterinary feed directive drugs
- § 355. New drugs
- § 355-1. Risk evaluation and mitigation strategies
- § 355a. Pediatric studies of drugs
- § 355b. Adverse-event reporting
- § 355c. Research into pediatric uses for drugs and biological products
- § 355c-1. Report
- § 355d. Internal committee for review of pediatric plans, assessments, deferrals, deferral extensions, and waivers
- § 355e. Pharmaceutical security
- § 355f. Extension of exclusivity period for new qualified infectious disease products
- § 356. Expedited approval of drugs for serious or life-threatening diseases or conditions
- § 356-1. Accelerated approval of priority countermeasures
- § 356a. Manufacturing changes
- § 356b. Reports of postmarketing studies
- § 356c. Discontinuance or interruption in the production of life-saving drugs
- § 356c-1. Annual reporting on drug shortages
- § 356d. Coordination; task force and strategic plan
- § 356e. Drug shortage list
- § 356f. Hospital repackaging of drugs in shortage
- § 357. Repealed.]
- § 358. Authority to designate official names
- § 359. Nonapplicability of subchapter to cosmetics
- § 360. Registration of producers of drugs or devices
- § 360a. Clinical trial guidance for antibiotic drugs
- § 360a-1. Clinical trials
- § 360b. New animal drugs
- § 360c. Classification of devices intended for human use
- § 360c-1. Reporting
- § 360d. Performance standards
- § 360e. Premarket approval
- § 360e-1. Pediatric uses of devices
- § 360f. Banned devices
- § 360g. Judicial review
- § 360g-1. Agency documentation and review of significant decisions regarding devices
- § 360h. Notification and other remedies
- § 360h-1. Program to improve the device recall system
- § 360i. Records and reports on devices
- § 360j. General provisions respecting control of devices intended for human use
- § 360k. State and local requirements respecting devices
- § 360l. Postmarket surveillance
- § 360m. Accredited persons
- § 360n. Priority review to encourage treatments for tropical diseases
- § 360n-1. Priority review for qualified infectious disease products
prev | next
- § 351. Adulterated drugs and devices
- § 352. Misbranded drugs and devices
- § 353. Exemptions and consideration for certain drugs, devices, and biological products
- § 353a. Pharmacy compounding
- § 353b. Prereview of television advertisements
- § 354. Veterinary feed directive drugs
- § 355. New drugs
- § 355-1. Risk evaluation and mitigation strategies
- § 355a. Pediatric studies of drugs
- § 355b. Adverse-event reporting
- § 355c. Research into pediatric uses for drugs and biological products
- § 355d. Internal committee for review of pediatric plans, assessments, deferrals, and waivers
- § 355e. Pharmaceutical security
- § 356. Fast track products
- § 356-1. Accelerated approval of priority countermeasures
- § 356a. Manufacturing changes
- § 356b. Reports of postmarketing studies
- § 356c. Discontinuance of life saving product
- § 357. Repealed.]
- § 358. Authority to designate official names
- § 359. Nonapplicability of subchapter to cosmetics
- § 360. Registration of producers of drugs or devices
- § 360a. Clinical trial guidance for antibiotic drugs
- § 360b. New animal drugs
- § 360c. Classification of devices intended for human use
- § 360d. Performance standards
- § 360e. Premarket approval
- § 360e-1. Pediatric uses of devices
- § 360f. Banned devices
- § 360g. Judicial review
- § 360h. Notification and other remedies
- § 360i. Records and reports on devices
- § 360j. General provisions respecting control of devices intended for human use
- § 360k. State and local requirements respecting devices
- § 360l. Postmarket surveillance
- § 360m. Accredited persons
- § 360n. Priority review to encourage treatments for tropical diseases
The table below lists the classification updates, since Jan. 3, 2012, for the contained sections. If there are multiple sections, they are presented in section number order (original document order).
The most recent Classification Table update that we have noticed was Tuesday, May 21, 2013
An empty table indicates that we see no relevant changes listed in the classification tables. If you suspect that our system may be missing something, please double-check with the Office of the Law Revision Counsel.
LII has no control over and does not endorse any external Internet site that contains links to or references LII.